Jackie Collins


Expert Discusses Best Practices for Managing Breast Cancer–Related Toxicities

March 14, 2022

Charles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.

Apalutamide Induces Impressive PSA Response and Solid Adherence Rates in Men with nmCRPC

September 23, 2021

Real-world evidence recently presented at the 2021 AUA Annual Meeting showed that high adherence rates and favorable prostate-specific antigen (PSA) response were observed in men with nmCRPC who were treated with apalutamide.